# Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-efficacy-and-safety-of-janus-kinase-inhibitors-for-covid-19-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ching-Yi Chen,Wang‐Chun Chen,Chi‐Kuei Hsu,Chien‐Ming Chao,Chih‐Cheng Lai |
| Citations | 31 |
| DOI | 10.1016/j.intimp.2021.108027 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/8324418 |
| OpenAlex ID | https://openalex.org/W3187130350 |
| PMID | 34343937 |
| Type | review |
| Year | 2021 |

## Paper authors

- [Ching-Yi Chen](https://scholariq.org/researchers/ching-yi-chen/)

## Paper journal

- [International Immunopharmacology](https://scholariq.org/journals/international-immunopharmacology/)

## Paper primary topic

- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

## Paper topics

- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)
- [interferon and immune responses](https://scholariq.org/topics/interferon-and-immune-responses/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.